NCT01515878

Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS

Hemocontrol's Effectiveness in a RAndomized Controlled Trial on the Reduction of Cardiovascular Long-term EventS

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 396 (estimated)
• Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

It is hypothesized that a consistent use of the Hemocontrol TM biofeedback function improves long-term cardiovascular outcome, mediated by reduced hypertension due to fluid overload and by reduced incidence of intradialytic hypotensive episodes

Conditions

• Kidney Failure Chronic
• Cardiovascular Diseases

Interventions

Type	Name	Description
DEVICE	Hemocontrol	Blood Volume Tracking system using biofeedback

Timeline

• Start date: 2012-02-01
• Primary completion: 2015-03-01
• Completion: 2015-03-01
• First posted: 2012-01-24
• Last updated: 2012-07-06

Locations

3 sites across 3 countries: Canada, France, Italy